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ABSTRACT
Introduction Frailty is a common condition affecting 
older adults and is associated with increased mortality 
and adverse outcomes. Identification of older adults at risk 
of adverse outcomes is central to subsequent resource 
planning and targeted interventions. This systematic 
review and meta- analysis will examine the: (1) diagnostic 
accuracy of the Clinical Frailty Scale (CFS) in identifying 
hospitalised adults ≥65 years with frailty and a medical 
diagnosis compared with the reference standard Frailty 
Index or Frailty Phenotype and (2) predictive value of the 
CFS in determining those at increased risk of subsequent 
adverse outcomes.
Methods and analysis We will include cross- sectional, 
retrospective and prospective cohort studies, and 
randomised controlled trials that assess either the 
diagnostic accuracy of the CFS when compared with 
the reference standard Frailty Index/Frailty Phenotype or 
the predictive validity of the CFS to predict subsequent 
adverse outcomes in hospitalised adults over 65 years 
with medical complaints. Adverse outcomes include falls, 
functional decline, unplanned Emergency Department 
attendance, emergency rehospitalisation, nursing home 
admission or death. A systematic search will be conducted 
in Embase, AMED, MEDLINE (Ebsco, Ovid, Pubmed), 
CINAHL, PsycINFO, Cochrane Library. Studies will be 
limited to those published from 2005 to 30 October 2019. 
Two independent reviewers will screen all titles and 
abstracts to identify relevant studies. The methodological 
quality of studies will be independently assessed using 
the Quality Assessment of Diagnostic Accuracy Studies-2. 
A CFS score of >4 will be used to identify frailty. We will 
construct 2×2 tables and determine true positives, true 
negatives, false positives and false negatives for each 
study when compared with the reference standard and for 
each adverse outcome. A bivariate random effects model 
will be applied to generate pooled summary estimates of 
sensitivity and specificity.
Ethics and dissemination Ethical approval is not 
required for this systematic review. We will disseminate 
our findings through a peer- reviewed journal.
INTRODUCTION
Frailty is a common condition that affects 
older adults across all settings of care.1 Clegg 
et al describe frailty as ‘a state of vulnerability 
to poor resolution of homeostasis following 
a stress and is a consequence of cumulative 
decline in multiple physiological systems over 
a lifespan’.2 It is a common presentation in 
Emergency Departments (EDs) but can be 
poorly defined due to ambiguity relating to 
its definition and pathophysiology. There 
are two current schools of thought relating 
to frailty. In the phenotypic model, frailty is 
viewed as a clinical syndrome with associated 
symptoms: unintentional weight loss, self- 
reported exhaustion, weakness, slow walking 
speed and low physical activity.3 Patients are 
usually defined as not frail, prefrail or frail. 
The second theory relates to the cumulative 
deficit model. Rockwood et al derived the 
Frailty Index whereby frail patients accumu-
late more conditions or symptoms associ-
ated with frailty. ‘The more individuals have 
wrong with them, the more likely they are to 
be frail’.4
Global demographics collated by the WHO 
indicate that more than 20% of the popu-
lation will be aged over 60 years by 2050.5 
Recent findings from the Irish Longitudinal 
Study on Ageing (TILDA) demonstrated that 
24.6% of patients over the age of 65 in Wave 
Strengths and limitations of this study
 ► No previous reviews have been published explor-
ing the predictive value of the Clinical Frailty Scale. 
Should a relevant review be published during the 
preparation of our review, it will be incorporated into 
our review and meta- analysis if relevant.
 ► Clinical and methodological heterogeneity across 
studies may limit our ability to draw reliable conclu-
sions from the available evidence.
 ► We will employ standardised reporting guidelines to 
enhance transparency in conducting and reporting 
the systematic review.
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1 are living with frailty and 45% were prefrail as per the 
frailty index.1
There is an increasing body of literature demonstrating 
that frailty is associated with adverse outcomes including 
falls, functional decline, unplanned ED attendance, 
emergency hospitalisation, nursing home admission and 
death.3 4 Early identification of older adults at risk of such 
adverse outcomes through systematic screening can serve 
to identify high- risk groups in need of timely and targeted 
assessment and intervention either in the hospital or in 
the community setting.6 In 2011, Sternberg et al identified 
20 different tools to identify frailty.7 Due to the heteroge-
neity of these tools, it can be difficult for the non- specialist 
to screen for frailty accurately and easily. Attempting to 
pick the appropriate tool is challenging due to a lack of 
consensus on a reference standard screening tool which 
is easily applicable to clinical practice. One of the more 
common screening tools used is the Clinical Frailty Scale 
(CFS) which was developed in Dalhousie by Rockwood et 
al in 2005. It was initially derived as a 7- point scale where 
individuals are classified as very fit to severely frail. It is 
based on functional status and underlying comorbidi-
ties.8 Due to the complex nature of severe frailty, the scale 
was extended to 9 points in 2008.9
Table 1 illustrates the CFS. A score of >4 points indi-
cates that the person is frail. Since its derivation, a 
number of studies have attempted to validate the CFS. 
The overall aim of this systematic review and meta- analysis 
is to examine the: (1) diagnostic accuracy of the CFS as a 
frailty screening tool compared with the reference stan-
dard Frailty Index or Frailty Phenotype in hospitalised 
adults ≥65 years with medical complaints and (2) predic-
tive value of the CFS in determining hospitalised adults 
≥65 years with medical complaints who are at increased 
risk of adverse outcomes.
METHODS
Study design
A systematic review and meta- analysis will be completed 
to identify relevant studies that assess either the diag-
nostic accuracy of the CFS when compared with the 
reference standard Frailty Index or Frailty Phenotype 
or the predictive validity of the CFS to predict adverse 
outcomes among hospitalised older adults with medical 
complaints. The review will adhere to the principles 
outlined in the Cochrane Handbook for Systematic 
reviews of Diagnostic Test Accuracy.10 We will also refer-
ence the Preferred Reporting Items for Systematic 
Reviews and Meta- Analyses standardised reporting guide-
lines to standardise the conduct and reporting of the 
research.11
Search methods
A systematic search will be conducted in Embase, AMED, 
MEDLINE (Ebsco, Ovid, Pubmed), CINAHL, PsycINFO, 
Cochrane Library to identify relevant studies. A combi-
nation of the following keywords and search terms will 
be applied across the databases: Clinical Frailty Scale 
OR Rockwood Clinical Frailty Scale AND older adult OR 
retired OR geriatric OR aged OR aging OR elderly (online 
supplemental file 1) contains the precise search strategy 
for MEDLINE Pubmed. There will be no language restric-
tion. We will limit our search to studies after 2005 when 
the CFS was first published. We will not search in grey 
literature or unpublished studies.
Study selection
Studies will be included based on the PEOSS (popula-
tion, exposure, outcomes, study design and setting of 
care) criteria. The population of interest includes hospi-
talised older adults over 65 years of age. We will include 
studies with a predominantly older population (mean or 
median age of the population ≥65 years). Our exposure 
of interest is the CFS. We will include studies that have 
examined the original 7- item CFS scale8 and the modi-
fied 9- item CFS scale.9 Outcomes of interest will include 
the diagnostic accuracy of the CFS when compared with 
the reference standard Frailty Index or Frailty Phenotype. 
In terms of the predictive accuracy of the CFS, adverse 
outcomes will include falls, injuries including fractures, 
functional decline, unplanned ED attendance, emer-
gency hospitalisation, length of stay, nursing home admis-
sion and death. In the case of falls, we will be guided by 
the method and definition used to report falls in each 
individual paper. For example, we will take into account 
the rate of falls, number of falls and time to fall. We will 
include all cross- sectional (including baseline data from 
longitudinal studies), prospective and retrospective 
cohort study designs and randomised controlled trials. 
Setting of care will only include hospitalised medical 
patients. We will exclude abstracts which have not had 
a subsequent full- text peer- reviewed publication. We 
will also exclude studies the primary focus of which are 
patients in intensive care, surgical patients, patients with 
cardiac diseases, patients with renal disorders and patients 
with orthopaedic conditions.
All searches will be imported into endnote and dupli-
cates will be removed. Two reviewers (AL and MO’C) will 
independently screen all titles and abstracts in the afore-
mentioned databases for inclusion using the prespecified 
inclusion criteria. Where there are any disagreements 
regarding studies for inclusion, they will be resolved by 
a third independent reviewer (RG). A proposed data 
extraction table is included in the supplementary data 
(See online supplemental file 2).
Table 1 CFS scores
  CFS 7 point scale CFS 9 point scale
Non frail 1–4 1–4
Frail 5–7 5–9
CFS, Clinical Frailty Scale.
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Quality assessment
Two reviewers (AL, MO’C) will independently review the 
methodological quality of each study using Quality Assess-
ment of Diagnostic Accuracy Studies (QUADAS-2) tool.12 
This tool consists of four key domains: Patient Selection, 
Index Test (CFS), Reference Standard (Frailty Index or 
Frailty Phenotype or adverse outcome) and Flow and 
Timing. For each individual study, the domains are eval-
uated in terms of risk of bias and the first three domains 
are evaluated with regards to concerns about applicability. 
Each of the independent reviewers will apply a rating of 
high, low or unclear across each of the domains through 
signalling questions included in the QUADAS-2 tool. If 
there is a conflict, it will be resolved by consensus where 
possible, in the event of no agreement, there will be a 
third independent reviewer (RG). The validity of each 
reported Frailty Index will be assessed using the criteria 
outlined by Searle et al.13
Statistical analysis
We will conduct statistical analysis using Stata V.13. We 
will construct individual 2×2 tables and determine true 
positives, true negatives, false positives and false nega-
tives for each study, for the reference standard and 
each adverse outcome. If additional data are required, 
we will contact the relevant authors to obtain the raw 
data in order to complete the 2×2 tables. We will calcu-
late summary estimates of sensitivity and specificity 
with 95% CIs using the bivariate random effects model 
and plot them on a receiver- operating characteristic 
graph. Statistical heterogeneity will be explored using 
the variance of logit- transformed sensitivity and speci-
ficity, where smaller values indicate less heterogeneity 
between studies. In terms of the predictive accuracy 
of the CFS, Bayes’ theorem will be used to estimate 
the post- test probability of an adverse outcome.14 The 
c statistic or area under the curve, with 95% CI will be 
employed to describe model discrimination. Values 
between 0.7 and 0.9 represent moderate accuracy and 
values greater than 0.9 represent high accuracy.15 We 
will perform sensitivity analyses to examine the impact 
of methodological quality on the predictive value of the 
CFS. We will perform a subgroup analysis to explore the 
diagnostic accuracy of the CFS against each reference 
standard individually. Publication bias will be assessed 
using funnel plots.
Certainty of the evidence
We will use GRADE criteria to assess the certainty of 
the evidence from the meta- analysis. As per the GRADE 
guidelines, each study will be allocated a ranking of 
high or low based on the type of study. Each will then 
be upgraded or downgraded based on quality of the 
studies.16 The overall GRADE scores will inform our 
decision to make recommendations from our systematic 
review based on the quality of the studies included in the 
meta- analysis.
Patient and public involvement (PPI)
Patients and public were not involved in the conceptu-
alisation or writing of the protocol for this review. The 
research questions addressed in this review arose from 
clinical observations of older adults. We will include PPI in 
the dissemination of our systematic review. We have estab-
lished a PPI group of older adults at the Ageing Research 
Centre at UL and we will engage with a subgroup of this 
cohort of older adults who will review our paper and 
provide input.
DISCUSSION
The CFS is a common tool that is used to screen for frailty. 
This systematic review will investigate the diagnostic and 
predictive accuracy of the CFS for identifying frailty and 
adverse outcomes among hospitalised older adults with 
medical complaints. Our two reference standards, the 
Frailty Index and the Frailty Phenotype, reflect the deficit 
model and phenotypic model of measuring frailty. These 
two reference standards measure different constructs of 
frailty and we will examine the diagnostic accuracy of the 
CFS against both reference standards individually and 
collectively.
With an ageing population, increasing numbers of 
older patients are presenting to acute hospital services. 
Our proposed systematic review specifically explores the 
diagnostic and predictive accuracy of the CFS in an older 
hospitalised patient cohort with medical complaints The 
risk of subsequent adverse outcomes including functional 
decline and increased dependency has been reported to 
be high and often permanent among hospitalised older 
adults.17 Research indicates that frail older adults are 
more than twice as likely to experience a poor outcome 
than their non- frail counterparts.18 Identifying frail older 
adults who are at higher risk of adverse outcomes will 
support practitioners in targeting resource- intensive 
frailty interventions.
The reference standard approach to the management 
of frailty is the Comprehensive Geriatric Assessment 
(CGA). Ellis et al describe the CGA as a complex multifac-
eted approach where older adults are assessed and have 
appropriate intervention by specialist geriatric services in 
a holistic and multidisciplinary fashion.19 In a Cochrane 
review of CGA for older adults admitted to hospital, it was 
found that patients who had CGA were more likely to be 
alive and in their own homes at 3–12 month follow- up 
(RR: 1.06; 95% CI: 1.01 to 1.10).20 Other interventions 
that have been explored with varying impact include 
physiotherapy, exercise regimes, nutritional support, 
multidisciplinary team input and pharmacological inter-
ventions.21 This proposed systematic review will serve to 
explore the totality of evidence regarding the diagnostic 
and predictive accuracy of the CFS in identifying a high- 
risk hospitalised older medical cohort which may benefit 
from CGA.
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